Page last updated: 2024-10-28

miltefosine and Leukemia, Promyelocytic, Acute

miltefosine has been researched along with Leukemia, Promyelocytic, Acute in 2 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hochhuth, C1
Berkovic, D1
Eibl, H2
Unger, C1
Doenecke, D1
Shoji, M1
Raynor, RL1
Fleer, EA1
Vogler, WR1
Kuo, JF1

Other Studies

2 other studies available for miltefosine and Leukemia, Promyelocytic, Acute

ArticleYear
Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells.
    Journal of cancer research and clinical oncology, 1990, Volume: 116, Issue:5

    Topics: Antigens, Surface; Antineoplastic Agents; Blotting, Northern; Cell Transformation, Neoplastic; DNA P

1990
Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells.
    Lipids, 1991, Volume: 26, Issue:2

    Topics: Cell Differentiation; Cell Line; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Phospholipid Ethe

1991